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ABSTRACT 
In recent years, mesenchymal stem cells have provoked much attentiveness in the field of regenerative 
medicine because of their differentiation potential and the capability to facilitate tissue repair via the 
emancipation of biologically active molecules. They have gained interest because of their distinctive curative 
properties. Mesenchymal stem cells are isolated from the Wharton’s jelly part of umbilical cord possessing 
higher proliferation capacity, immunomodulatory activity, plasticity, as well as self-renewal capacity than the 
mesenchymal stem cells from various origins, and it is considered to be the best resource for allogeneic 
transplantation. The isolated umbilical cord-derived mesenchymal stem cells are cultured in the Dulbecco’s 
Modified Eagle’s Medium, and thereby it begins to release soluble factors into the medium during the period of 
culture which is termed as conditioned medium. This conditioned media has both differentiation capacity and 
therapeutic functions. Thus, it can be able to differentiate the cells into different lineages and the paracrine 
effect of these cells helps in replacement of the damaged cells. This medium may accord to optimization of 
diagnostic and prognostic systems as well as the generation of novel and targeted therapeutic perspectives. 
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INTRODUCTION 
   Mesenchymal stem cells (MSCs) are considered to 
be multipotent stromal cells that are derived from 
the mesoderm with self-renewal capacity 1. 
Friedenstein et al. first published his report on 
explaining the expansion of adherent and spindle 
shaped cells derived from human bone marrow 2. 
These MSCs have the ability to differentiate into 
various lineages which include osteocytes (bone 
cells), chondrocytes (cartilage cells), myocytes 
(muscle cells) and adipocytes (fat cells) 3. The usual 
functioning role of mesenchymal stromal cells is 
maintaining the tissue homeostasis by 
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differentiating towards the tissue specific cell types, 
proliferation and also by emancipating the growth 
factors and immunoregulatory agents 4. Some 
recent evidence stipulates that the MSCs assist in 
tissue regeneration through hindrance or inhibition 
of unwanted immune reactions and impart growth 
factors rather than directly restoring the damaged 
cells 5. 
These multipotent adult stem cells have been 
isolated from different tissues, including bone 
marrow, adipose tissue, umbilical cord, cord blood, 
amniotic fluid, peripheral blood, placenta, fetal 
lung, etc 6. These MSCs have immunosuppressive 
and anti-inflammatory effects, which might 
constitute an interesting source for curative 
applications. They also inhibit the maturation of 
dendritic cells, enhancement of anti-inflammatory 
functions and declination of the production of 
cytokines 2. Bone marrow is previously considered 
as the chief source of MSCs, but their number 
begins to decrease significantly with age and this 
has led to the discovery of numerous alternative 
sources. When compared to bone marrow-derived 
stem cells, the umbilical cord-mesenchymal stem 
cells (UC-MSCs) have less human leukocyte antigen-
II (HLA-II) and major histocompatibility complex 
(MHC) class I molecules. These UC-MSCs have been 
proposed as a candidate for numerous clinical 
applications. The conditioned medium (CM) derived 
from MSCs was also found to have similar clinical 
applications as that of MSCs from the previous 
studies.  So, it is imperative to understand the 
application and therapeutic properties of the CM. 
 
Human umbilical cord derived-mesenchymal stem 
cells (UC-MSCs) 
The MSCs are obtained from various umbilical cord 
(UC) compartments or from the complete UC. This 
UC generally possesses about four compartments as 
a source of MSCs:  
1. The whole UC is cut into minute pieces or 
fragments and thereby following the enzymatic 
digestion process or explant techniques.  
2. The Wharton’s jelly (WJ) MSCs is acquired by 
removal of the UC vessels (arteries and vein). The 
umbilical cord arteries (UCA) and veins (UCV) 
(umbilical vessels) can also be minced into minute 
fragments and then plated for the growth of MSCs.  
3. The sub-amnion part of the lining membrane is 
unfastened with a blade, and it is cut into minute 
pieces.  
4. The extracted vessels from the cord have to be 
tied at the two ends in a kind of loop. The loops will 
be presented in an enzymatic solution for a definite 
period of time to make the cells to dissociate from 
the perivascular part 7.  
Thus, these MSCs are generally isolated by enzyme 
digestion process as well as density gradient 
centrifugation. The isolated cells were plated in a 
complete culture medium with the supplements 
and maintained at 37°C under 5% CO2. Cell growth 
are analyzed by direct cell counts 2.  
Other than the general advantages such as painless 
collection approach and rapid self-renewal ability, 
UC-MSCs has displayed the capacity to differentiate 
into three different germ layers to accumulate in 
the damaged tissue or inflamed regions and to 
provoke tissue repair. These MSCs which are 
isolated from Wharton’s jelly of UC have higher 
proliferation capacity, immunomodulatory activity, 
plasticity as well as self-renewal ability than MSCs 
derived from various origins and are considered to 
be the best resource for allogeneic transplantation. 
These UC-MSCs are characterized by high safety, 
abundance, less immunogenicity and shorter 
amplification times. Most of the research studies 
show that these circulating MSCs are attracted to 
the sites of damage or inflamed regions where it 
undergoes tissue-specific differentiation (Figure 1). 
 
Figure 1. Paracrine effect of mesenchymal stem cells (MSCs) in tissue 
regeneration 
 
Conditioned medium from UC-MSCs 
The isolated UC-derived MSCs are cultured in the 
Dulbecco’s Modified Eagle’s Medium (DMEM) 
medium, and thereby it begins to emancipate 
certain soluble factors into the medium during the 
period of culture which is termed as CM (Figure 2). 
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Figure 2. Collection of conditioned medium (CM) from human umbilical 
cord-mesenchymal stem cells (UC-MSCs) 
 
 
These factors that are secreted thereby promote 
anti-oxidant, immunosuppressive and cell 
proliferative effects at the transplant regions. The 
CM has both differentiation capacity and 
therapeutic function. Thus, it can be able to 
differentiate the cells into different lineages and the 
paracrine effect of these cells helps in replacement 
of the damaged cells. This derived CM might 
intensify the positive effects of cell-based therapies. 
Since UC-CM contains increased levels of growth 
factors and chemokines, they normally accord to a 
chemoattractive environment of the adjacent 
tissues 8. The growth factors and cytokines secreted 
from adipose tissue-derived MSCs have been 
elucidated in previous studies (Table 1) 9. 
 
 
Table 1: Growth factors, cytokines and chemokines secreted by human 
adipose tissue derived mesenchymal stem cells (MSCs) in the 
conditioned medium 
Factors Role 
IL-6 It prevents differentiation, apoptosis induced by serum 
starvation and as well as enhances proliferation of 
undifferentiated MSCs. 
VEGF Plays a vital role in angiogenesis, post-natal homeostasis, 
and skeletal development and also regulates the 
differentiation of MSCs by modulating the levels of 
RUNX2 and PPARγ transcription factors. 
Angiogenin Interaction with endothelial cell induces broad range of 
cellular responses such as cellular proliferation, cell 
migration and tube formation, etc. and plays a vital role 
in stimulating angiogenesis. 
MCP-1,3 These chemokines acts as a MSC homing factor, the 
overexpression of MCP signals the MSCs to identify the 
site of injured tissue and restores the damaged cells. 
IGF-1 It plays a vital role in regulating neuronal functions. It 
suppresses neuronal apoptosis and reduces 
inflammatory reactions. 
bFGF Triggers FGF receptors which activate P13K/Akt signaling 
pathway. Thereby it induces human MSC migration via a 
FGFR/ P13K/Akt pathway. 
 
DISCUSSION 
Clinical applications of conditioned medium 
There are various therapeutic applications for CM, 
including anti-photoaging properties and 
accelerating the wound healing with fewer scars. It 
also helps to induce apoptosis and differentiation. 
Moreover, it plays an important role in inducing 
migration and angiogenesis, preventing muscle 
atrophy, possessing anti-fibrotic properties and 
regenerating capacities. It does help in suppressing 
proteolytic system and the ROS generation in 
muscle atrophied cells 10-12 (Figure 3). The diverse 
studies on the secreted factors derived from stem 
cells exhibited that the secreted soluble factors 
without the stem cells might provoke tissue repair 
in different conditions that involved in organ or 
tissue damage 13. Previous studies have examined 
the pro-angiogenic properties of UC-MSCs which 
have been described as exhibited in vitro. The 
impact of the CM on proliferation of human 
umbilical vein-derived endothelial EA.hy926 cells 
was quantified. The major alterations in the cell 
motility and undeviating migration were evaluated 
by the scratch-wound healing and trans-well 
chamber migration assays. Their studies indicated 
that VEGF-A independent paracrine activity 
mechanism and partially VEGF-A independent 
differentiation mechanism are generally implicated 
in the pro-angiogenic activity of UC-MSCs 14. 
 
Figure 3. Clinical applications of conditioned medium (CM) derived from 
human umbilical cord-mesenchymal stem cells (UC-MSCs) 
 
 
In a study, the regenerative impacts and the 
controlling mechanisms of UC-MSC derived CM 
were investigated in the atrophied muscles by 
utilizing an in vivo model, and their findings 
suggested that CM imparts a constructive stimulus 
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to perpetuate the muscle status and function in 
atrophied muscles. Therefore, they concluded that 
the use of UC-CM will perform as a promising 
therapeutic approach for further expansion of cell-
free therapies in muscle regeneration 12. MSCs 
derived from UC have also proven the cutaneous 
wound healing by means of paracrine mechanism. 
The dermal fibroblasts which were treated with the 
CM from UC-MSCs were found to additionally treat 
the wounds and displayed accelerated healing with 
fewer scars when compared to the controls 10.  
Another study examined the curative effect of 
UCMSC-CM on muscle-linked diseases by utilizing a 
dexamethasone (Dex)-induced muscle atrophy in 
vitro model. The expression of the muscle atrophy- 
linked proteins was found to be increased by 
around 50-70% when the L6 cells were exposed to 
Dex. The expression of muscle-specific proteins was 
in a way decreased by around 23–40%. In contrast, 
these L6 cells when co-treated with UCMSC-CM and 
Dex, the muscle atrophy-linked proteins shows a 
reduced expression in a UCMSC-CM dose-
dependent manner and the expression of muscle-
specific proteins was recovered to the near-usual 
levels. Besides, the ROS generation was found to be 
suppressed and expression of anti-oxidant enzymes 
was restored to a normal degree. These data 
implicates that the UCMSC-CM clearly has the 
capacity to treat muscle atrophy 11. 
Previous studies have also demonstrated the anti-
photoaging effects following chronic ultraviolet (UV) 
irradiation in both in vitro and in vivo of conditioned 
serum-free medium (SFM) derived from UC-MSCs 
were assessed. This UC-SFM had a restorative 
impact on the human dermal fibroblast 
proliferation and decreased UV-A induced cell 
death. Furthermore, UCMSC-SFM chunked UV-A 
obstruction of superoxide dismutase activity. The 
topical application of UCMSC-SFM to the mouse 
skin prior to UV irradiation chunked the hampering 
of superoxide dismutase and glutathione 
peroxidase activities and lessened the up-regulation 
of malonaldehyde. Thus, UCMSC-SFM protects 
against photoaging instigated by UV-A and UV-B 
radiation and is found to be a much assuring 
candidate for the skin anti-photoaging treatments15. 
Taken together, all the previous existing studies 
reveal that the use of UC-CM might be suitable for 
regenerative medicine. 
 
CONCLUSION 
   MSCs are population of stem cells with greater 
self-renewal and multipotentiality. MSCs are 
potential seed cells in regenerative medicine and 
have been used for the treatment of various 
diseases. Stem-cell therapy, especially UC-MSCs, is a 
promising alternative to treat on-going tissue 
damage by resetting the underlying disease process 
through alteration of the mucosal immune 
response. Moreover, they are proven to settle in 
the inflamed sites to repair injured tissues. Recent 
findings suggest that MSC-CM have similar 
properties like MSCs and favourable antitumor 
characteristics as well. The understanding of these 
mechanisms and CM may contribute to the 
optimization of diagnostic and prognostic systems 
as well as the generation of novel and targeted 
therapeutic perspectives. 
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